Standard BioTools (LAB) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Company Participants ​John Graziano - Vice President of Investor RelationsMichael Egholm - President & CEOAlex Kim - CFOPaul Knight - Managing Director Conference Call Participants Kyle Boucher - AnalystMatthew Stanton - Analyst Operator Please note this event is being recorded. I would now like to turn the conference over to John Graziano, Vice President of Investor Relations. Please go ahead. ​John Graziano Thank you, operator, and goo ...

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the "Company" or "Standard BioTools") today announced financial results for the first quarter ended March 31, 2025. Recent Highlights: "Standard BioTools delivered a solid first quarter in line with our expectations, reflecting focused execution in a challenging Life Sciences macro backdrop," said Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools. "We remain grounded and discipli ...